Skip to content
Disclosery

Atle Fund Management AB

Follow

13F filer, CIK 1381843, STOCKHOLM, Sweden

Atle Fund Management AB reported $26,969,048 across 38 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-04. Its ten largest share positions make up 53.8% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001381843-25-000009

Period
2025-09-30
Reported value
$27M
Holdings
38
Top 10 weight
53.8%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KRYSadded+22,033$413K
RNAMnew+51,978$240K
ONCadded+5,947$215K
NBIXadded+14,233$212K
CELCnew+37,157$195K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VERONA PHARMA PLCexited-47,100-$4.45M
BSXreduced-39,505-$409K
AMGNreduced-10,088-$302K
VRTXreduced-6,562-$273K
SYKreduced-4,697-$184K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001381843-25-000009, largest first. % of portfolio is the value over $26,969,048, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,564 shares; 2024Q4: 37,068 shares; 2025Q1: 34,602 shares; 2025Q2: 38,721 shares; 2025Q3: 37,244 shares 37,244$3.02M11.19%-1,477Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,486 shares; 2024Q4: 90,723 shares; 2025Q1: 89,227 shares; 2025Q2: 86,933 shares; 2025Q3: 92,105 shares 92,105$2.26M8.4%+5,172Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,607 shares; 2024Q4: 67,763 shares; 2025Q1: 75,881 shares; 2025Q2: 88,392 shares; 2025Q3: 102,625 shares 102,625$1.53M5.67%+14,233Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 154,699 shares; 2024Q4: 105,727 shares; 2025Q1: 127,679 shares; 2025Q2: 139,172 shares; 2025Q3: 160,913 shares 160,913$1.43M5.32%+21,741Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,012 shares; 2024Q4: 24,896 shares; 2025Q1: 22,857 shares; 2025Q2: 24,266 shares; 2025Q3: 27,147 shares 27,147$1.4M5.18%+2,881Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 10,900 shares; 2025Q1: 25,141 shares; 2025Q2: 24,386 shares; 2025Q3: 30,333 shares 30,333$1.1M4.07%+5,947Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 53,432 shares; 2024Q4: 103,032 shares; 2025Q1: 151,348 shares; 2025Q2: 165,480 shares; 2025Q3: 174,722 shares 174,722$963K3.57%+9,242Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 36,544 shares; 2024Q4: 32,553 shares; 2025Q1: 31,553 shares; 2025Q2: 31,466 shares; 2025Q3: 28,608 shares 28,608$949K3.52%-2,858Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 15,345 shares; 2025Q2: 18,559 shares; 2025Q3: 19,707 shares 19,707$936K3.47%+1,148Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 76,998 shares; 2025Q2: 73,165 shares; 2025Q3: 78,169 shares 78,169$921K3.42%+5,004Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 106,172 shares; 2024Q4: 154,222 shares; 2025Q1: 132,273 shares; 2025Q2: 126,185 shares; 2025Q3: 86,680 shares 86,680$898K3.33%-39,505Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,460 shares; 2024Q4: 25,660 shares; 2025Q1: 22,998 shares; 2025Q2: 27,466 shares; 2025Q3: 22,769 shares 22,769$894K3.31%-4,697Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 236,610 shares; 2024Q4: 266,499 shares; 2025Q1: 214,778 shares; 2025Q2: 227,224 shares; 2025Q3: 252,875 shares 252,875$805K2.99%+25,651Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,202 shares; 2024Q4: 9,202 shares; 2025Q1: 23,491 shares; 2025Q2: 20,158 shares; 2025Q3: 42,191 shares 42,191$791K2.93%+22,033Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 16,993 shares; 2024Q4: 22,257 shares; 2025Q1: 22,808 shares; 2025Q2: 24,328 shares; 2025Q3: 17,766 shares 17,766$739K2.74%-6,562Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 138,321 shares; 2024Q4: 116,692 shares; 2025Q1: 77,263 shares; 2025Q2: 106,912 shares; 2025Q3: 93,605 shares 93,605$729K2.7%-13,307Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 138,983 shares; 2024Q4: 138,983 shares; 2025Q1: 107,783 shares; 2025Q2: 157,223 shares; 2025Q3: 193,625 shares 193,625$585K2.17%+36,402Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,547 shares; 2025Q2: 25,302 shares; 2025Q3: 29,991 shares 29,991$548K2.03%+4,689Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 36,505 shares; 2024Q4: 68,296 shares; 2025Q1: 59,696 shares; 2025Q2: 57,360 shares; 2025Q3: 65,659 shares 65,659$542K2.01%+8,299Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 27,500 shares; 2024Q4: 30,680 shares; 2025Q1: 27,688 shares; 2025Q2: 26,797 shares; 2025Q3: 30,297 shares 30,297$505K1.87%+3,500Timeline
UFPTUFP TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,048 shares; 2024Q4: 23,159 shares; 2025Q1: 21,259 shares; 2025Q2: 21,886 shares; 2025Q3: 22,986 shares 22,986$487K1.81%+1,100Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,687 shares; 2024Q4: 62,521 shares; 2025Q1: 35,292 shares; 2025Q2: 59,889 shares; 2025Q3: 47,999 shares 47,999$480K1.78%-11,890
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 26,390 shares; 2024Q4: 30,940 shares; 2025Q1: 37,098 shares; 2025Q2: 40,532 shares; 2025Q3: 60,156 shares 60,156$432K1.6%+19,624Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 62,161 shares; 2025Q1: 54,961 shares; 2025Q2: 82,275 shares; 2025Q3: 85,355 shares 85,355$423K1.57%+3,080Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 28,965 shares; 2024Q4: 27,414 shares; 2025Q1: 26,577 shares; 2025Q2: 23,894 shares; 2025Q3: 13,806 shares 13,806$414K1.53%-10,088Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 53,757 shares; 2024Q4: 60,057 shares; 2025Q1: 45,841 shares; 2025Q2: 50,872 shares; 2025Q3: 50,872 shares 50,872$363K1.35%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 119,833 shares; 2025Q2: 147,380 shares; 2025Q3: 203,755 shares 203,755$342K1.27%+56,375Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 24,652 shares; 2025Q3: 45,690 shares 45,690$321K1.19%+21,038Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,490 shares; 2024Q4: 35,202 shares; 2025Q1: 25,782 shares; 2025Q2: 13,727 shares; 2025Q3: 13,727 shares 13,727$298K1.1%0Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 151,875 shares; 2024Q4: 120,501 shares; 2025Q1: 91,301 shares; 2025Q2: 86,274 shares; 2025Q3: 92,074 shares 92,074$269K1%+5,800Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 51,978 shares 51,978$240K0.89%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 69,573 shares; 2024Q4: 98,304 shares; 2025Q1: 98,304 shares; 2025Q2: 175,582 shares; 2025Q3: 175,582 shares 175,582$236K0.87%0Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,230 shares; 2024Q4: 42,071 shares; 2025Q1: 44,171 shares; 2025Q2: 25,732 shares; 2025Q3: 25,732 shares 25,732$224K0.83%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 86,013 shares; 2024Q4: 101,177 shares; 2025Q1: 105,077 shares; 2025Q2: 92,737 shares; 2025Q3: 92,737 shares 92,737$203K0.75%0Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 442,423 shares; 2024Q4: 479,644 shares; 2025Q1: 479,644 shares; 2025Q2: 1,105,461 shares; 2025Q3: 1,169,634 shares 1,169,634$202K0.75%+64,173Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 37,157 shares 37,157$195K0.72%newTimeline
MREOMEREO BIOPHARMA GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 200,000 shares; 2024Q4: 390,000 shares; 2025Q1: 390,000 shares; 2025Q2: 764,901 shares; 2025Q3: 764,901 shares 764,901$167K0.62%0Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 39,573 shares; 2025Q1: 46,808 shares; 2025Q2: 49,820 shares; 2025Q3: 49,820 shares 49,820$129K0.48%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VERONA PHARMA PLCVERONA PHARMA PLC47,100$4.45Mshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001381843-25-000009 base2025-11-04acceptance time not in the bulk data set